INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 158 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $551 | +8.7% | 41,037 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $507 | -99.9% | 41,037 | -28.3% | 0.00% | 0.0% |
| Q3 2022 | $797,000 | +169.3% | 57,195 | +166.7% | 0.00% | – |
| Q2 2022 | $296,000 | -70.5% | 21,442 | -65.2% | 0.00% | -100.0% |
| Q1 2022 | $1,002,000 | +45.0% | 61,615 | +45.2% | 0.00% | 0.0% |
| Q4 2021 | $691,000 | +265.6% | 42,421 | +454.3% | 0.00% | – |
| Q4 2020 | $189,000 | +626.9% | 7,653 | +1079.2% | 0.00% | – |
| Q3 2020 | $26,000 | -92.0% | 649 | -90.4% | 0.00% | – |
| Q2 2020 | $325,000 | +282.4% | 6,795 | +401.1% | 0.00% | – |
| Q1 2020 | $85,000 | – | 1,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |